Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cytogenetic and molecular genetic aspects of eosinophilic leukaemias.

× No keyword cloud information.

9 in total

1. Case of chronic eosinophilic leukemia with deletion of chromosome 16 and hepatitis C.

Authors: Padma Kamineni; Ayanna Baptiste; Mukhtar Hassan; Fitzroy W Dawkins; Syed Zaidi; Ayalew Tefferi; Mercedes Lindsey; Lekidelu Taddesse-Heath
Journal: J Natl Med Assoc Date: 2006-08 Impact factor: 1.798

2. Idiopathic hypereosinophilic syndrome: a rare cause of erythroderma.

Authors: Vikram K Mahajan; Ravinder Singh; Karaninder S Mehta; Pushpinder S Chauhan; Saurabh Sharma; Mrinal Gupta; Ritu Rawat
Journal: J Dermatol Case Rep Date: 2014-12-31

3. Molecular analysis of chronic eosinophilic leukemia with t(4;10) showing good response to imatinib mesylate.

Authors: Haruko Tashiro; Ryosuke Shirasaki; Mitsuho Noguchi; Moritaka Gotoh; Kazuo Kawasugi; Naoki Shirafuji
Journal: Int J Hematol Date: 2006-06 Impact factor: 2.490

4. Response to imatinib mesylate in a patient with idiopathic hypereosinophilic syndrome associated with cyclic eosinophil oscillations.

Authors: Shinsaku Imashuku; Naoki Kakazu; Ikuyo Ueda; Akira Morimoto; Hironori Harada; Tomoko Teramura; Shinichi Tamura; Yoko Fukushima-Nakase; Hiroshi Kuroda
Journal: Int J Hematol Date: 2005-05 Impact factor: 2.490

Review 5. [Hypereosinophilic syndrome and Churg-Strauss syndrome: is it clinically relevant to differentiate these syndromes?].

Authors: B Hellmich; K Holl-Ulrich; H Merz; W L Gross
Journal: Internist (Berl) Date: 2008-03 Impact factor: 0.743

Review 6. Imatinib therapy in clonal eosinophilic disorders, including systemic mastocytosis.

Authors: Ayalew Tefferi; Animesh Pardanani
Journal: Int J Hematol Date: 2004-06 Impact factor: 2.490

7. Chronic eosinophilic leukemia with the FIP1L1-PDGFRalpha fusion gene in a patient with a history of combination chemotherapy.

Authors: Yasuhiro Tanaka; Masayuki Kurata; Katsuhiro Togami; Haruyuki Fujita; Naoko Watanabe; Akiko Matsushita; Akinori Maeda; Kenichi Nagai; Akiko Sada; Toshimitsu Matsui; Takayuki Takahashi
Journal: Int J Hematol Date: 2006-02 Impact factor: 2.490

Review 8. Eosinophilic disorders in various diseases.

Authors: Jocelyn Celestin; Marianne Frieri
Journal: Curr Allergy Asthma Rep Date: 2012-02 Impact factor: 4.919

9. Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality.

Authors: Shinya Rai; J Luis Espinoza; Yasuyoshi Morita; Hirokazu Tanaka; Itaru Matsumura
Journal: Front Immunol Date: 2019-01-09 Impact factor: 7.561

9 in total